[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100221153":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":20,"locations":25,"responsibleParty":46,"collaborators":49,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":65,"sex":71,"minAge":72,"maxAge":10,"enrollmentInfo":73,"targetDuration":10,"studyType":76,"phases":10,"briefSummary":77,"conditions":78,"keywords":82,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":89,"lastUpdatePostDateStruct":90,"startDateStruct":93,"completionDateStruct":95,"leadSponsor":97,"locationsCount":98},{"fullName":5,"class":6},"Johannes Gutenberg University Mainz","OTHER",[8,11,13],{"label":9,"type":10,"description":10,"interventionNames":10},"Cohort 1: Suspect of Pulmonary Embolism (PE)",null,{"label":12,"type":10,"description":10,"interventionNames":10},"Cohort 2: Suspect of Deep Vein Thrombosis (DVT)",{"label":14,"type":10,"description":10,"interventionNames":10},"Cohort 3: Incidental Venous Thromboembolism (VTE)",[16],{"name":17,"affiliation":18,"role":19},"Philipp S Wild, MD, MSc","University Medical Center of Johannes Gutenberg University Mainz, Germany","PRINCIPAL_INVESTIGATOR",[21],{"name":17,"role":22,"phone":23,"phoneExt":10,"email":24},"CONTACT","0049 6131 17 7163","philipp.wild@unimedizin-mainz.de",[26],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"University Medical Center of the Johannes Gutenberg University Mainz","RECRUITING","Mainz","Rhineland-Palatinate","55131","Germany","DE",{"type":35,"coordinates":36},"Point",[37,38],8.28008,49.98185,{"lat":38,"lon":37},[41,43,44],{"name":17,"role":22,"phone":42,"phoneExt":10,"email":24},"00496131177163",{"name":17,"role":19,"phone":10,"phoneExt":10,"email":10},{"name":45,"role":19,"phone":10,"phoneExt":10,"email":10},"Stavros Konstantinides, MD, FESC",{"type":19,"investigatorFullName":47,"investigatorTitle":48,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Philipp Wild, MD, MSc","Univ.-Prof. Dr. med. Philipp Wild, MSc",[50,52,54,56,59,61],{"name":51,"class":6},"Maastricht University",{"name":53,"class":6},"Hochschule Fresenius",{"name":55,"class":6},"University of Bonn",{"name":57,"class":58},"Siemens Corporation, Corporate Technology","INDUSTRY",{"name":60,"class":58},"Bayer",{"name":62,"class":58},"Eurofins","100221153","vteval-project---prospective-cohort-studies-to-evaluate-and-improve-diagnostics-management-strategies-and-risk-stratification-in-vte-100221153",false,"NCT02156401","VTEval Project - Prospective Cohort Studies to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in VTE","VTEval Project - Three Observational, Prospective Cohort Studies Including Biobanking to Evaluate and Improve Diagnostics, Management Strategies and Risk Stratification in Venous Thromboembolism","VTEval","Inclusion Criteria:\n\n* Age ≥18 years and Informed written consent\n* Clinical condition:\n\n  * Cohort 1: Clinical suspicion of acute PE (with or without DVT)\n  * Cohort 2: Clinical suspicion of acute DVT (without symptomatic PE)\n  * Cohort 3: Incidentally diagnosed VTE","ALL","18 Years",{"count":74,"type":75},2000,"ESTIMATED","OBSERVATIONAL","Venous thromboembolism (VTE) with its two clinical manifestations deep vein thrombosis (DVT) and pulmonary embolism (PE) is a life-threatening disease that is associated with considerable morbidity and mortality. The incidence of VTE increases with age and it - as the third most common cardiovascular disease after ischemic heart disease and stroke - represents an important public health problem in industrialized countries with several aspects in need to be addressed.\n\nVTEval Project includes three long-term prospective observational studies to evaluate and improve VTE diagnostics and management, treatment and outcome. The aims of the project include a systematic assessment of VTE, i.e. disease status (symptoms, clinical and subclinical aspects) and risk profiles (classic, psychosocial and environmental factors), using a system-oriented approach. VTEval collects three large prospective cohorts of patients with suspected and incident VTE consisting of individuals with a clinical suspicion of acute PE, individuals with a clinical suspicion of acute DVT, and individuals with incidental diagnosis of VTE).\n\nThe standardized and harmonized data acquisition of the study establishes a sustainable resource for comprehensive research on VTE, thus providing the basis for both short- and long-term analysis.",[79,80,81],"Venous Thromboembolism (VTE)","Deep Vein Thrombosis (DVT)","Pulmonary Embolism (PE)",[83,84,85,86,87,88],"Venous thromboembolism","Deep vein thrombosis","Pulmonary embolism","Cohort study\u002Fepidemiology","Outcome","Prognosis","2024-06-14",{"date":91,"type":92},"2024-06-17","ACTUAL",{"date":94,"type":92},"2013-04",{"date":96,"type":75},"2030-07",{"name":5,"class":6},1]